Form 4: Keurig Dr Pepper CHRO Receives Significant RSU Grants

Sentiment:

Insider Transaction Report


Keurig Dr Pepper's Chief Human Resources Officer, Mary Beth DeNooyer, reported new Restricted Stock Unit grants and routine vesting transactions.

Summary

  • Mary Beth DeNooyer, Chief Human Resources Officer of Keurig Dr Pepper Inc. (KDP), reported several transactions involving company stock and Restricted Stock Units (RSUs).
  • On March 5, 2026, 6,757 Restricted Stock Units (RSUs) converted into common stock on a one-for-one basis, originating from a grant made on March 5, 2025.
  • Following the RSU conversion, 3,404 shares of common stock were withheld for the payment of applicable taxes at a price of $28.05 per share.
  • After these transactions, the beneficial ownership of common stock decreased from 99,575 shares to 96,171 shares.
  • On March 4, 2026, DeNooyer was granted 31,175 new Restricted Stock Units (RSUs) with a vesting schedule of 25% annually from March 4, 2027, to March 4, 2030.
  • Additionally, on March 4, 2026, DeNooyer received another grant of 83,132 new Restricted Stock Units (RSUs), vesting one-third annually from March 4, 2027, to March 4, 2029.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development, reflecting routine executive compensation that aligns management incentives with long-term company performance, despite a minor reduction in direct common stock ownership due to tax withholding.

Positives

  • The significant grants of 31,175 and 83,132 new Restricted Stock Units (RSUs) align the Chief Human Resources Officer's long-term incentives with shareholder value.
  • The conversion of 6,757 RSUs into common stock demonstrates the realization of previously granted equity compensation.

Negatives

  • A disposition of 3,404 shares of common stock occurred for tax withholding purposes, reducing direct common stock ownership.

Future Outlook

The vesting schedules for the newly granted Restricted Stock Units (RSUs) extend through March 2030, indicating a long-term incentive structure for the Chief Human Resources Officer and an implied commitment to the company's future performance.

Industry Context

StockSavvy.ai notes that these insider transactions are routine executive compensation events, common across publicly traded companies. The granting of Restricted Stock Units (RSUs) is a standard practice to align the interests of key management personnel with the long-term performance and shareholder value of the company, particularly in the consumer staples sector where talent retention is crucial.

Stakeholder Impact

  • Shareholders: The RSU grants reinforce management's long-term commitment to the company, potentially benefiting shareholders through sustained performance alignment.

Next Steps

  • Future vesting of the 31,175 Restricted Stock Units (RSUs) on March 4, 2027, 2028, 2029, and 2030.
  • Future vesting of the 83,132 Restricted Stock Units (RSUs) on March 4, 2027, 2028, and 2029.
  • Future vesting of the remaining 20,271 Restricted Stock Units (RSUs) from the March 5, 2025 grant on March 5, 2027, 2028, and 2029.

Key Dates

DateDescription
03/05/2025Grant date for a tranche of Restricted Stock Units (RSUs) that began vesting on March 5, 2026.
03/04/2026Acquisition date for new grants of 31,175 and 83,132 Restricted Stock Units (RSUs).
03/05/2026Conversion of 6,757 Restricted Stock Units (RSUs) into common stock and subsequent disposition of 3,404 shares for tax withholding.
03/06/2026Signature date of the Form 4 filing.
03/04/2027First vesting date for the 31,175 RSU grant (25%) and the 83,132 RSU grant (one-third).
03/05/2027Second vesting date for the 2025 RSU grant (25%).
03/04/2028Second vesting date for the 31,175 RSU grant (25%) and the 83,132 RSU grant (one-third).
03/05/2028Third vesting date for the 2025 RSU grant (25%).
03/04/2029Third vesting date for the 31,175 RSU grant (25%) and the 83,132 RSU grant (one-third).
03/05/2029Final vesting date for the 2025 RSU grant (25%).
03/04/2030Final vesting date for the 31,175 RSU grant (25%).

Recommendation

hold

This Form 4 filing details routine executive compensation, including new RSU grants and the vesting of prior awards, which is a standard practice to align management incentives with long-term shareholder value. It does not contain any material information that would warrant a change in investment thesis or a strong buy/sell recommendation for Keurig Dr Pepper Inc. The transactions are expected and do not indicate a significant shift in company fundamentals or outlook.

Keywords

Keurig Dr Pepper, KDP, Insider Transaction, Form 4, Restricted Stock Units, RSU, Executive Compensation, Stock Grant, Vesting

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.